Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CBO Medicare Rx Costs: Thomas Plan Is $155 Bil. Under House Set-Aside

Executive Summary

The House leadership will have approximately $155 bil. to use under this year's budget resolution to enhance its Medicare Rx proposal, according to the Congressional Budget Office's revised cost estimates for drug benefit proposals

You may also be interested in...



House Medicare Rx Bill Authorizes Tiered Co-Pays, De-Emphasizes Mail

The draft House Republican Medicare prescription drug bill includes language explicitly authorizing tiered co-pays

House Medicare Rx Bill Authorizes Tiered Co-Pays, De-Emphasizes Mail

The draft House Republican Medicare prescription drug bill includes language explicitly authorizing tiered co-pays

Medicare Rx Premium Of $35 Would Keep Two-Thirds Of Seniors Out – AARP

A Medicare drug benefit premium of $35 a month would keep two-thirds of eligible beneficiaries from enrolling in the program, AARP told a Senate Finance Committee hearing March 7

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS039648

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel